microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2

The Potential Value of the PI3K/Akt/mTOR Signaling Pathway for Assessing Prognosis in Cervical Cancer and as a Target for Therapy

(2017) Afsane Bahrami et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Parthenolide induces apoptosis and autophagy through the suppression of PI3K/Akt signaling pathway in cervical cancer

(2016) Sridharan Jeyamohan et al.   BIOTECHNOLOGY LETTERS

Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway

(2016) Tingting Feng et al.   Oncotarget

Review of the Cervical Cancer Burden and Population-Based Cervical Cancer Screening in China

(2015) Jiangli Di et al.   Asian Pacific Journal of Cancer Prevention

Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway

(2015) XUE BAI et al.   ONCOLOGY REPORTS

miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL

(2015) Lin Chen et al.   TUMOR BIOLOGY

PARP2 Is the Predominant Poly(ADP-Ribose) Polymerase in Arabidopsis DNA Damage and Immune Responses

(2015) Junqi Song et al.   PLoS Genetics

MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a

(2014) Joana Ribeiro et al.   MOLECULAR BIOLOGY REPORTS

Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor

(2013) Zhanwen He et al.   MEDICAL ONCOLOGY

MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor

(2013) Min Luo et al.   SURGERY

MiR-383 is Downregulated in Medulloblastoma and Targets Peroxiredoxin 3 (PRDX3)

(2012) Kay Ka-Wai Li et al.   BRAIN PATHOLOGY

The Role of PARP-1 and PARP-2 Enzymes in Metabolic Regulation and Disease

(2012) Péter Bai et al.   Cell Metabolism

MicroRNA-214 Suppresses Growth and Invasiveness of Cervical Cancer Cells by Targeting UDP-N-acetyl-α-d-galactosamine:PolypeptideN-Acetylgalactosaminyltransferase 7

(2012) Rui-Qing Peng et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Transactivation of microRNA-383 by Steroidogenic Factor-1 Promotes Estradiol Release from Mouse Ovarian Granulosa Cells by Targeting RBMS1

(2012) Mianmian Yin et al.   MOLECULAR ENDOCRINOLOGY

miR-375 Is Down-Regulated in Squamous Cervical Cancer and Inhibits Cell Migration and Invasion via Targeting Transcription Factor SP1

(2011) Fenfen Wang et al.   AMERICAN JOURNAL OF PATHOLOGY

Identification of candidate substrates for poly(ADP-ribose) polymerase-2 (PARP2) in the absence of DNA damage using high-density protein microarrays

(2011) Sonia Troiani et al.   FEBS Journal

Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis

(2011) Mohammad H Forouzanfar et al.   LANCET

Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway

(2011) C L Au Yeung et al.   ONCOGENE

The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening

(2011) Channa E. Schmeink et al.   REVIEWS IN MEDICAL VIROLOGY

Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses

(2011) Heba W. Z. Khella et al.   TUMOR BIOLOGY

Downregulation of microRNA-383 is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation by targeting IRF1

(2011) J Lian et al.   Cell Death & Disease

Crystal Structure of the Catalytic Domain of Human PARP2 in Complex with PARP Inhibitor ABT-888

(2010) Tobias Karlberg et al.   BIOCHEMISTRY

Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites

(2009) Matthias Altmeyer et al.   NUCLEIC ACIDS RESEARCH

Altered microRNA expression in patients with non-obstructive azoospermia

(2009) Jie Lian et al.   Reproductive Biology and Endocrinology

DNA repair deficiency as a therapeutic target in cancer

(2008) Sarah A Martin et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT